Physician

Psychiatry

Michael Garvey practices Psychiatry. He researched medicine at Stanford University School of Medicine. Stanford University School of Medicine is a one of the best medicals schools. Stanford University School of Medicine has a rank of 2 in research and a 25 in primary care Doctor Michael J. Garvey, MD has written publications. He has 71 publications published with PubMed. The lastest paper is: 'An association of NAG levels and a mutation of the CCK gene in panic disorder patients.'

Publications

---

• Emulsification of silicone oil and eye movements.
• Increasing the extensional viscosity of silicone oil reduces the tendency for emulsification.
• NAG level differences in panic disorder and agoraphobia.
• Long-term follow-up after a drug trial for panic disorder.
• A report of trazodone-associated laboratory abnormalities.
• Does 24-h urinary MHPG predict treatment response to antidepressants? II. Association between imipramine response and low MHPG.
• Does 24-h urinary MHPG predict treatment response to antidepressants? I. A review.
• Response of depression to very high plasma levels of imipramine plus desipramine.
• Do low levels of MHPG in depressive spectrum patients normalize after successful treatment?
• Fine T-cell subsets in alcoholics as determined by the expression of L-selectin, leukocyte common antigen, and beta-integrin.
• Is there a relationship between MHPG and anxiety in depressed patients?
• Cognitive impairment in the euthymic phase of chronic unipolar depression.
• Changes in urinary MHPG during treatment of depression with imipramine.
• Are some symptoms of depression age dependent?
• Association of levels of N-acetyl-beta-glucosaminidase with specific psychiatric symptoms in bipolar patients.
• Examination of pre- and posttreatment MHPG during cognitive therapy.
• A comparative trial of fluoxetine versus trazodone in outpatients with major depression.
• Serum fluoxetine and norfluoxetine concentrations and antidepressant response.
• Association of affective disorder with migraine headaches and neurodermatitis.
• Comparison of color preference in depressives and controls.
• The relationship of panic disorder to agoraphobia.
• Low levels of MHPG in depressive spectrum patients.
• Is DST status associated with depression characteristics?
• Antidepressant response in chronic major depression.
• Comparison of seasonal and nonseasonal affective disorders.
• The association of MHPG to dexamethasone suppression test status.
• Dextroamphetamine treatment of mania.
• Do depressed patients with higher pretreatment stress levels respond better to cognitive therapy than imipramine?
• Urinary levels of 3-methoxy-4-hydroxyphenylglycol predict symptom severity in selected patients with unipolar depression.
• Is carbamazepine associated with NAG elevations suggestive of renal disease?
• Relationship of N-acetyl-beta- glucosaminidase levels to seriousness of suicide attempts.
• Association of N-acetyl-beta-glucosaminidase levels with seriousness of suicide attempts.
• Does situational panic disorder represent a specific panic disorder subtype?
• Psychiatric family history and urinary MHPG in healthy control subjects.
• Frequency of constipation in major depression: relationship to other clinical variables.
• The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder.
• Benzodiazepines for panic disorder. Are they safe?
• Topical fumagillin in the treatment of microsporidial keratoconjunctivitis in AIDS.
• On patient compliance with medication doses.
• Closure of a bronchopleural fistula using decalcified human spongiosa and a fibrin sealant.
• The association of urinary 5-hydroxyindoleacetic acid and vanillylmandelic acid in patients with generalized anxiety.
• The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels.
• The effect of silica nanoparticulate coatings on cellular response.
• An association between the lysosomal enzyme NAG and urinary free cortisol and platelet imipramine binding.
• Association of NAG levels with specific psychiatric symptoms in unipolar patients.
• Personality disorder traits in generalized anxiety and panic disorder patients.
• Examination of comorbid anxiety in psychiatric inpatients.
• Comparison of panic disordered patients with high versus low MHPG.
• Comparison of major depressive patients with a predominantly sad versus anxious mood.
• The association of the serotonin metabolite, 5-HIAA, to the lysosomal enzyme N-acetyl-beta-glucosaminidase.
• Benzodiazepine withdrawal: a review of the evidence.
• The reliability of urinary 5-HIAA levels.
• Relationship of generalized anxiety symptoms to urinary 5-hydroxyindoleacetic acid and vanillylmandelic acid.
• Preliminary confirmation of the proposed link between reward-dependence traits and norepinephrine.
• Reduction of gastrointestinal symptoms following treatment for panic disorder.
• Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
• Predictors of serious suicide attempts among patients with panic disorder.
• Effects of a nanoparticulate silica substrate on cell attachment of Candida albicans.
• Anxiety and the menstrual cycle in panic disorder.
• The occurrence of a prodrome of generalized anxiety in panic disorder.
• Association of levels of N-acetyl-beta-glucosaminidase with severity of psychiatric symptoms in panic disorder.
• Elevated levels of N-acetyl-beta-glucosaminidase in affective disorders and chemical dependence.
• An association of NAG levels and a mutation of the CCK gene in panic disorder patients.
• Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study.
• Follow-up study of patients with panic disorder and agoraphobia with panic attacks treated with tricyclic antidepressants.
• Diazepam versus alprazolam for the treatment of panic disorder.
• A biological difference between panic disorder and generalized anxiety disorder.
• Generalized anxiety disorder vs. panic disorder. Distinguishing characteristics and patterns of comorbidity.
• Injectability of silicone oil-based tamponade agents.
• Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime.

Schools

---

• Stanford University

• Iowa

• Iowa Psychology Hospital

Doctors Specialties

---

• Psychiatry

Accepted Insurances

---

Education

---

• University of Iowa Hospitals and Clinics
• Stanford University
• Stanford University School of Medicine

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Kimberly Y. Verhoef, MD This Doctor is OpenDoctor Recommended.
	Dr. Richard H. Rinehart, MD
	Dr. David J. Mair, MD
	Dr. Linda K. Madson, MD This Doctor is OpenDoctor Recommended.
	Dr. Ricardo E. Jorge, MD
	Dr. Gary R. Gaffney, MD This Doctor is OpenDoctor Recommended.
	Dr. Sarah A. Adlakha, DO
	Dr. Jess Fiedorowicz, MD This Doctor is OpenDoctor Recommended.
	Dr. Victor W. Swayze II, MD This Doctor is OpenDoctor Recommended.
	James C. Brown
	Dr. Anvi K. Vora, MD
	Dr. Susan M. Duffy, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog